- Lightest weighing ECG patch in the market designed for comfort and ease of use
- Embedded with Samsung’s Next-Generation bio-processor proven to capture world’s most accurate ECG waveforms
SEOUL, South Korea, Sept. 13, 2023 /PRNewswire/ — Wellysis, a spin-off company from Samsung SDS, has received clearance from the U.S. Food and Drug Administration (FDA) on August 30, 2023, to market its wearable electrocardiography (ECG) patch, S-Patch Ex, in the U.S. The product, which received EU’s CE mark in May 2021, is currently being exported to 14 countries worldwide, including UK, Spain, Italy, Greece, Poland, Australia, Thailand, India, and Korea.
The S-Patch Ex is an ECG and heart rate recording device for use by healthcare professionals and patients both at home and in clinical settings. The product is embedded with Samsung…
